The main department of described VC is located in the Munich. The company was established in Europe in Germany.
The fund is generally included in less than 2 deals every year. The common things for fund are deals in the range of 1 - 5 millions dollars. The real fund results show that this VC is 0 percentage points less often commits exit comparing to other companies. The important activity for fund was in 2007.
The standard case for the fund is to invest in rounds with 1-2 partakers. Despite the BioScience Ventures Group, startups are often financed by Limburg Ventures. The meaningful sponsors for the fund in investment in the same round are NV Industriebank LIOF, Limburg Ventures, High-Tech Gru00fcnderfonds. In the next rounds fund is usually obtained by The Austrian Research Promotion Agency (FFG).
Besides, a startup requires to be at the age of 4-5 years to receive the investment from the fund. For fund there is no match between the country of its foundation and the country of its the most frequent investments - Austria. Among the most successful fund investment fields, there are Biotechnology, Biopharma. Among the most popular portfolio startups of the fund, we may highlight APEPTICO Forschung und Entwicklung, ugichem.
Related Funds
Funds with similar focus
Fund Name | Location |
7-Eleven | Irving, Texas, United States |
Atlas Holdings | Connecticut, Greenwich, United States |
CoreNetwork Fund | Ohio, Toledo, United States |
Dash Fund | - |
Doing Now | Beijing, Beijing, China |
Dutch Technology Foundation STW | Netherlands, Utrecht, Utrecht |
GRIDS Capital | Brazil, São Paulo, São Paulo |
GT-MAX | - |
Huoerguosi Jiubang Xinxi Jishu Youxian Gongsi | - |
Joyo Industrial Research Institute | Ibaraki Prefecture, Japan, Mito |
Modea | Blacksburg, United States, Virginia |
NBP Asia Investments | - |
Paladin Labs | Canada, Montreal, Quebec |
Perspective Capital Management | - |
Rogers Communications | Canada, Ontario, Toronto |
SP Investment Associates (SPIA) | - |
Straus Partners | Denmark, Holstebro, Midtjylland |
Woofoo Capital | China, Shanghai |
Notable deals
Company | Industry | Round Size | Date | Investors | Location |
MagnaMedics | 01 Feb 2011 | Limburg | |||
$4M | 05 Aug 2010 | Vienna, Austria | |||
Diaferon | $927K | 09 Jul 2007 | Munich, Bavaria, Germany | ||
$1M | 17 May 2007 | Innsbruck, Tyrol, Austria |
1. You post comments at your own choice and risk. You bear the whole responsibility,related to their substance, content and the fact of publication. We shall not bear anyliability in respect of such comments.
2. While commenting, you shall use only actual, truthful and confirmed data. In thesame time you shall not use vulgar, abusive or defamatory language as well as expresshatred or call to violence or cruelty.
3. We do not intend to delete any comments on the website unless within our “noticeand take down” procedure.
4. We can moderate comments at any time.
5. While commenting, you are under the rule of our website’s terms of use and privacypolicy.
6. We retain our right to delete any comment or any other content of the website at ourwill in case we know or suppose such content is illegal or breaches any lawful right.
Review
- No reviews are submitted yet.
Sign up and get access to full fund profile and advanced analysis.
Latest deals
Company | Industry | Round Size | Date | Investors | Location |
MagnaMedics | 01 Feb 2011 | Limburg | |||
$4M | 05 Aug 2010 | Vienna, Austria | |||
Diaferon | $927K | 09 Jul 2007 | Munich, Bavaria, Germany | ||
$1M | 17 May 2007 | Innsbruck, Tyrol, Austria |